Sonnet BioTherapeutics Holdings, Inc. ( SONN) - Key Metrics
Stock symbol SONN is outdated, potentially delisted? Maybe it is available on other exchange?
SONN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | ? | -$0.70 | -$0.61 | -$0.61 |
| 2024Q2 | ? | $0.08 | $0.16 | $0.16 |
| 2024Q1 | $0 | -$0.31 | -$0.81 | -$0.81 |
| 2023Q4 | $0.02 | -$2.09 | -$2.59 | -$2.69 |
| 2023Q3 | $0.03 | -$2.96 | -$4.62 | -$4.63 |
SONN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -2.67 |
| 2024Q2 | ? | 47.77 |
| 2024Q1 | ? | -11.31 |
| 2023Q4 | ? | -2.74 |
| 2023Q3 | ? | -7.29 |
SONN
Price: $3.10
52 week price:
Earnings Per Share: -6.82 USD
P/E Ratio: -0.18
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 442053
Market Capitalization: 8.4 million